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factors for dementiaIn this issue, Chen and colleagues report a significant as-
sociation betweenAlzheimer’s disease (AD) and vascular de-
mentia (VaD), and long-term exposure to particulate matter
(PM10) and ozone, in a retrospective case-control study in
the Taipei-Keelung metropolitan area [1]. The authors iden-
tified 249 AD cases, 125 VaD cases, and 497 controls aged
60 and older from neurology clinics and teaching hospitals
in the area. Air quality data were drawn from 24 air quality
monitoring stations in the Taipei-Keelung metropolitan
area. The adjusted odd ratios (AOR) they report for AD asso-
ciated with PM10 (AOR 5 4.17, 95% confidence interval or
CI 2.31–7.54) is higher than what is typically reported as
the risk associated between having one or more apolipopro-
tein E (APOE) 4 allele(s), one of the strongest genetic risk
factors for AD. Findings must be interpreted with caution,
however. The study is not without limitations, as assumptions
about duration of residence were made and temporality
cannot be established.
Although a number of studies have related air pollution
to health [2–4] and mortality [5,6], recent work has begun
to tie air pollution to cognitive impairment [7,8] and
structural brain aging [9]. This is one of the first studies
to show an association between air quality and significantly
increased risk for the two most common forms of dement-
ing illnesses. As our ability to test associations between air
pollution and AD improves (i.e., with the emergence of ge-
ospatial analysis and the ability to tie historical pollution
data to large epidemiological studies of incident dementia),
this should become an area of intense research interest in
the United States and elsewhere. It will be important to
evaluate these associations prospectively, in population-
based studies, and across a wide range of geographical
areas to establish the elements of causality including; tem-
porality, strength, evidence of a dose response, consistency,
plausibility, and specificity.
There are a number of reasons why this work is important.
First, as dementia researchers are well aware, the numbers of
new cases—and the financial burden of disease—is
increasing. According to the 2015 Facts and Figures report
[10], the cost of AD has risen to $226 billion dollars annu-
ally; the cost of VaD is likely higher on a per patient basis
[11] although the prevalence of VaD is lower. Second, ashttp://dx.doi.org/10.1016/j.dadm.2015.05.001
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licenses/by-nc-nd/4.0/).we are also painfully aware, no treatments to stop or slow
the progression of AD have been found. Recent failures of
AD clinical trials suggest that earlier intervention is neces-
sary. Third, in the absence of treatment, prevention becomes
paramount; and randomized controlled clinical trials of pre-
ventive interventions are in their infancy. Fourth, if a signif-
icant risk of exposure can be controlled on a societal level,
then the society has a responsibility to act. Published studies
on the health effects of air pollution are considered by the
Environmental Protection Agency (EPA) when determining
standards. In the provisional assessment of “new” science
for the evaluation of air quality standards, which occurs
every 5 years, the EPA found that there was “no evidence
of an association between long-term PM10-2.5 exposure and
mortality” [12]. This indicates that at the time of the last re-
view, not enough new evidence in support of changing the
standards had been published. There was no mention of
the effects of air pollution on cognition. A recent Cochrane
Review [13] highlighted the importance of studying this
issue, and the need for more data. They cited the EPA’s
report noting that the costs of public and private efforts in
the Unied States to meet the 1990 Clean Air Act Amendment
requirements are estimated at $65 billion annually [14]. That
is less than 1/3 the cost of AD per year in the United States,
not including the cost of VaD, unpaid care, and the burden on
families imposed by dementia. Acknowledging that air
pollution affects human health in countless other ways,
many of them very costly, one might speculate that we can
afford to do more.
With the exception of rare familial variants (APP, PS1,
PS2) and one risk gene (APOE), AD does not appear to be
primarily due to genetic risk factors. Although there are a
number of other genes with relatively small effects, and
genes most certainly contribute significantly to AD risk,
we have known for some time that genes account for only
a portion of the risk for AD. Other common risk or protective
factors have been studied including type 2 diabetes, hyper-
tension, diet, exercise, obesity, and cardiovascular disease.
To date, there has been relatively little study of the effects
of our environment on AD risk. Of all the factors that
contribute to AD, environmental exposures are one of very
few, if any, risk factors that can be addressed by societal oress article under the CC BY-NC-ND license (http://creativecommons.org/
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health, when a problem is life-threatening, affects a signifi-
cant portion of the population, and has a substantial societal
cost, the government has a duty to step in. As Newt Gingrich
noted in his recent op ed in the New York Times, “.when it
comes to breakthroughs that could cure—not just treat—the
most expensive diseases, government is unique. It alone can
bring the necessary resources to bear. (The federal govern-
ment funds roughly a third of all medical research in the
United States.) And it is ultimately on the hook for the costs
of illness” [15]. This study is just a starting point for thework
that needs to be done to build a case for action regarding the
effects of pollution on dementia risk. We need to rigorously
investigate the problem and build a body of supporting evi-
dence (if indeed the evidence support) to effect change. The
next EPA review of standards has begun; a call for informa-
tion on recent research was issued in December 2014 and re-
view should run through December 2017.Kathleen M. Hayden
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